Efficacy of Amprolium Re-Confirmed

reading time
Article | 09.12.2021
Ben Dehaeck DVM, Global Product Manager Anticoccidials

Article published in All About Feed, Volume 29 No 9

Amprolium was first introduced in the poultry industry in 1960 in the US. Ever since it has been a very successful coccidiostat around the world with applications in feed and water.

One of the most important diseases in poultry is coccidiosis, caused by infections with a highly contagious intestinal parasite of the genus Eimeria. An effective way to target this parasitic disease is the use of coccidiostats, mixed into feed. The EU has regulated the use of coccidiostats in regulation No 1831/2003 (the feed additive regulation).

Amprolium hydrochloride (amprolium) is a synthetic coccidiostat that does not possess any antibacterial activity, making it suitable for antibiotic-free production systems. Amprolium is one of the few synthetic compounds for which the mode of action is clearly described: due to its close structural similarity to thiamine (vitamin B1), it acts as a thiamine antagonist and competes for the absorption of thiamine by the Eimeria parasites.

Thiamine analogues, such as amprolium, block absorption of thiamine and, as a result, cause starvation of the parasite due to thiamine deficiency. The thiamine transport system in the parasite is more sensitive to amprolium than that of the host, which explains why this coccidiostat is safe for use in chickens. It seems especially efficacious during schizogony (one of the three phases of the life cycle of Eimeria) as the demand for thiamine is at its highest then, thus allowing the development of an immune response.

Results meta-analysis

Amprolium has been used intensively for a long time worldwide. To evaluate its efficacy after years of use, both in water (as treatment) and in feed (preventative) in the US, a meta-analysis on eight ASTs (anticoccidial sensitivity trials) was conducted. The Eimeria strains used to challenge the birds were collected in 2018 from eight different regions in the US. Each sample originated from a different state and/or complex and was composed of subsamples from multiple farms. Each strain was evaluated in an individual trial, conducted by the University of Georgia (US) using the same standardised protocol. 

Birds reared in a clean environment until 12 days of age were allocated to different groups:

  • uninfected untreated control (UUC)
  • infected untreated control (IUC)
  • infected treatment (IT)

The latter received amprolium in the feed at 125 ppm (registered dose) until the end of the trial. At 14 days of age, the birds were infected with the respective Eimeria strains collected from the different areas. At the end of the trials (seven days post infection), performance parameters were measured between day 12 (allocation) and the end (day 20). 

Suitable for ABF systems

Meta-analysis of the different AST trials showed that amprolium significantly reduced the feed conversion ratio (FCR) from 1.88 to 1.65 and increased the average daily gain from 41.2 g to 46.7 g compared with the IUC, indicating that amprolium is able to overcome the negative effects caused by the coccidiosis infection (Figure 1). 

Figure 1. Performance results of the meta-analysis conducted on eight samples collected in the US

These results confirmd the efficacy of amprolium to control coccidiosis under field conditions where the product was used extensively. In summary, amprolium (Coxam) has robust efficacy after many years of use and it is suitable for use in antibiotic-free (ABF) production systems.

global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us


Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .




North America


South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.


United States

Click here to visit the local website or close this popup to stay on the global website.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now